The breakthrough blood test uses AI to detect the 12 most lethal and common cancers from an mRNA signature which shows if ...

Cancer is one of the leading causes of death globally, with nearly 20 million new cases and 9.7 million deaths in 2022. Early ...

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced it will present 18 abstracts, ...

Nika Beamon set out on a journey, and 26 doctors, 37 procedures and more than 17 years later, a rheumatologist finally ...

Owlstone Medical ("Owlstone"), the global leader in Breath Biopsy ® for applications in early disease detection and precision ...

Key points A 5-year-old boy from rural east-central Ontario was referred to the urgent dermatology service with tender papulopustular and nodular lesions on the trunk, limbs, and face, which had ...

Shares of Iovance Biotherapeutics have plummeted post-Amtagvi approval. Read more to see a full investment analysis for IOVA ...

Out of curiosity she plugged her collection of symptoms into the artificial intelligence chatbot, Chat GPT. To her surprise, ...

Blood test analyses cell-free RNA to detect cancers, treatment resistance, and tissue injury, offering a powerful new tool ...

Companion Diagnostics MarketThe global market for companion diagnostics is set for exponential growth, projected to expand from USD 5,700.5 million in 2024 to USD 11,682.8 million by 2035, registering ...

Stanford Medicine researchers have developed a blood test capable of detecting cancers, the ways cancer resists treatments ...